TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Hyperfine ( (HYPR) ).
On October 15, 2025, Hyperfine, Inc. announced preliminary, unaudited financial results for the third quarter of 2025, highlighting strong business momentum following the launch of its next-generation Swoop® system. The company reported a 27% sequential revenue growth to approximately $3.4 million and a 36% increase in the average device selling price. The successful commercial rollout of the Swoop® system and Optive AI™ software has led to significant traction in the U.S. hospital pipeline, with new placements across critical care and emergency departments. This expansion signals a promising outlook for Hyperfine’s market positioning and stakeholder interests.
The most recent analyst rating on (HYPR) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Hyperfine stock, see the HYPR Stock Forecast page.
Spark’s Take on HYPR Stock
According to Spark, TipRanks’ AI Analyst, HYPR is a Neutral.
Hyperfine’s overall stock score is driven by strong technical momentum and positive earnings call insights, indicating potential growth and strategic advancements. However, significant profitability challenges and valuation concerns due to ongoing losses weigh down the score.
To see Spark’s full report on HYPR stock, click here.
More about Hyperfine
Hyperfine, Inc. is a health technology company that has revolutionized brain imaging with the Swoop® system, the first FDA-cleared, portable, ultra-low-field MRI system for brain imaging. The company focuses on providing accessible and clinically relevant diagnostic imaging to improve patient care globally.
Average Trading Volume: 461,721
Technical Sentiment Signal: Buy
Current Market Cap: $157.9M
Find detailed analytics on HYPR stock on TipRanks’ Stock Analysis page.